Suzetrigine for pain after ankle replacement
Treatments studied
Part of Pain clinical trials.
This study tests a new non-opioid pain medicine called suzetrigine to see how well it controls pain after ankle replacement surgery. The goal is to manage pain with fewer opioid-related side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are having your ankle joint replaced with an artificial joint (total ankle replacement).
- You are not currently taking opioid pain medicines.
- You do not have serious kidney or liver problems.
- You have not had heart failure or a recent heart attack.
- You are not taking certain blood thinners (like warfarin or apixaban).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-opioid pain medicine called suzetrigine (also known as Journavx) to see how well it controls pain after lower back surgery. It might be a good option if you're having lumbar fusion surgery and want to avoid the side effects of opioid painkillers.
This study tests a new non-opioid pain medicine called suzetrigine for pain after certain types of pelvic surgery. If it works, it might help you recover with fewer side effects than opioids.
This study tests a new non-opioid pain medicine called suzetrigine to see if it can control pain after vaginal pelvic surgery while reducing the need for opioid painkillers. If you are having this type of surgery soon, this trial might offer you an alternative for pain management.
This study tests whether adding suzetrigine to standard pain relief improves recovery after minimally invasive hysterectomy. Suzetrigine is a new type of painkiller that may reduce the need for opioids.
This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.
This study tests a new non-opioid pain reliever (suzetrigine) combined with other standard treatments to control pain after knee replacement surgery, with the goal of reducing opioid use. If effective, it could offer better pain control with fewer opioid-related risks.
Hear when a new Ankle Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.